These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 98920)

  • 1. Long-term survival in multiple myeloma.
    Gomez AR
    W V Med J; 1978 Aug; 74(8):181-3. PubMed ID: 98920
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term survival and prognostic factors in stage II-III multiple myeloma treated with conventional chemotherapy].
    Pertuiset E; Chevret S; Lioté F; Delauche MC; Bardin T; Dryll A; Kuntz D
    Ann Med Interne (Paris); 1992; 143(8):519-24. PubMed ID: 1303595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma.
    Harousseau JL; Attal M; Divine M; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M; Abgrall JF
    Stem Cells; 1995 Aug; 13 Suppl 2():132-9. PubMed ID: 8520502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors in the treatment of multiple myeloma].
    Antipova LG
    Ter Arkh; 1983; 55(8):59-63. PubMed ID: 6635958
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect.
    Khaled Y; Mellacheruvu S; Reddy P; Peres E; Mineishi S
    Bone Marrow Transplant; 2009 Sep; 44(5):325-6. PubMed ID: 19204708
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic criteria of survival in the treatment of Ewing's sarcoma, reticulosarcoma and myeloma].
    Tolstopiatov BA
    Vopr Onkol; 1980; 26(7):9-14. PubMed ID: 6996323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of statin use at the time of autologous transplant on response and survival in multiple myeloma.
    Hamadani M; Hade E; Benson DM; Hofmeister CC
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):351-2. PubMed ID: 18275902
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of the relation between staging and survival time in patients with multiple myeloma].
    Shindo T; Nishinarita S; Shimada H; Tomura K; Sawada S; Amaki I
    Rinsho Ketsueki; 1986 Mar; 27(3):307-14. PubMed ID: 3735684
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved long-term survival in multiple myeloma. Finnish Leukaemia Group.
    Eur J Haematol; 1989 Nov; 43(5):385-8. PubMed ID: 2612611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation.
    Lenhoff S; Hjorth M; Turesson I; Westin J; Gimsing P; Wislöff F; Ahlberg L; Carlson K; Christiansen I; Dahl IM; Forsberg K; Brinch L; Hammerström J; Johnsen HE; Knudsen LM; Linder O; Mellqvist UH; Nesthus I; Nielsen JL;
    Haematologica; 2006 Sep; 91(9):1228-33. PubMed ID: 16956822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma.
    Shimoni A; Smith TL; Aleman A; Weber D; Dimopoulos M; Anderlini P; Andersson B; Claxton D; Ueno NT; Khouri I; Donato M; Korbling M; Alexanian R; Champlin R; Giralt S
    Bone Marrow Transplant; 2001 Apr; 27(8):821-8. PubMed ID: 11477439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study on chemotherapy for multiple myeloma: Part IV: Prognostic factors related to long survival].
    Adachi T; Sezaki T; Hoshijima T; Izumi K; Tsubota T; Asano K; Takahashi I; Kimura I; Murakami M
    Rinsho Ketsueki; 1988 Apr; 29(4):494-501. PubMed ID: 3165478
    [No Abstract]   [Full Text] [Related]  

  • 14. Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.
    Hillengass J; Wasser K; Delorme S; Kiessling F; Zechmann C; Benner A; Kauczor HU; Ho AD; Goldschmidt H; Moehler TM
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):475-81. PubMed ID: 17255268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry.
    Kim SJ; Kim K; Kim BS; Jo DY; Kang HJ; Kim JS; Mun YC; Kim CS; Sohn SK; Eom HS; Kwak JY; Shim H; Yoon HJ; Jin JY; Min CK; Shin H; Won JH; Lee JJ; Kwon JH; Joo YD; Do YR; Kim SH; Oh S; Suh C; Lee J; Yoon SS; Kim MK; Bang SM; Ryoo HM; Kim BS; Kim H; Kim HJ; Kim YS; Park CW; Lee GW; Shin HJ; Park SK; Park JS; Kim HY; Lee DS; Lee JH;
    Acta Haematol; 2009; 122(4):200-10. PubMed ID: 19887776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple myeloma--diagnosis, prognostic factors and treatment].
    Kitani T
    Rinsho Ketsueki; 1995 May; 36(5):471-9. PubMed ID: 7783353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Socioeconomic status and survival in multiple myeloma].
    Pasqualetti P; Colantonio D; Collacciani A; Casale R
    Minerva Med; 1990 Oct; 81(10):713-6. PubMed ID: 2234467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
    Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term survival in multiple myeloma].
    Sakalová A; Mikulecký M; Dedík L; Prümmerová M; Gazová S; Chabronová I; Mistrík M; Lipsic T
    Vnitr Lek; 1994 Feb; 40(2):98-103. PubMed ID: 8140770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retrospective analysis of patients with multiple myeloma; clinical characteristics and prognostic factors].
    Zdziarska B
    Ann Acad Med Stetin; 1990; 36():179-94. PubMed ID: 2099106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.